Pulse Biosciences
PLSE
45.55
+1.14
+2.57%
Pulse Biosciences
US · PLSE
#2388 by market cap
Listed 2016
45.55
+1.14
+2.57%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B+
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 6 analysts
Buy
Avg price target 66.67 +46.4%
Price target rangecurrent 45.55
Low58.00
Avg66.67
High74.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (24)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-06 | CCORF | -- | Buy | 74.00 |
| 2026-11-06 | Mizuho Securities | -- | Buy | 65.00 |
| 2026-11-05 | BTIG | -- | Buy | 70.00 |
| 2026-10-13 | Mizuho Securities | -- | Buy | 55.00 |
| 2026-10-13 | Oppenheimer | -- | Buy | 60.00 |
| 2026-10-09 | BTIG | -- | Buy | 70.00 |
| 2026-10-07 | CCORF | -- | Buy | 58.00 |
| 2026-10-06 | CCORF | -- | Buy | 58.00 |
| 2026-10-06 | BTIG | -- | Buy | 70.00 |
| 2026-09-23 | BTIG | -- | Buy | 70.00 |
| 2026-09-09 | Freedom Capital Markets | -- | Buy | 73.00 |
| 2026-08-17 | Needham | -- | Buy | 58.00 |
| 2026-08-11 | CCORF | -- | Buy | 43.00 |
| 2026-08-10 | CCORF | -- | Buy | 43.00 |
| 2026-08-10 | Mizuho Securities | -- | Buy | 45.00 |
| 2026-07-28 | Oppenheimer | -- | Buy | 35.00 |
| 2026-06-04 | CCORF | -- | Buy | 32.00 |
| 2026-04-13 | Mizuho Securities | -- | Buy | 30.00 |
| 2026-02-20 | Mizuho Securities | -- | Buy | 30.00 |
| 2026-02-20 | Oppenheimer | -- | Buy | 30.00 |
| 2026-02-10 | Mizuho Securities | -- | Buy | 30.00 |
| 2026-02-06 | Mizuho Securities | -- | Buy | 30.00 |
| 2026-01-30 | Mizuho Securities | -- | Buy | 25.00 |
| 2025-11-06 | Oppenheimer | -- | Buy | 22.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | After close | ±17.14% | +0.41% (in line) |
| 2026/Q2 | 2026-08-06 | After close | ±13.89% | +10.90% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±26.40% | -2.60% (in line) |
| 2025/Q4 | 2026-02-19 | After close | ±21.77% | -14.59% (in line) |
| 2025/Q3 | 2025-11-05 | After close | ±31.19% | -3.32% (in line) |
| 2025/Q2 | 2025-08-12 | After close | ±20.73% | +11.19% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±23.31% | +1.31% (in line) |
| 2024/Q4 | 2025-03-27 | After close | ±21.87% | +6.00% (in line) |
| 2024/Q3 | 2024-10-30 | After close | ±15.23% | -1.64% (in line) |
| 2024/Q2 | 2024-08-12 | After close | ±12.43% | +8.05% (in line) |
| 2024/Q1 | 2024-05-07 | After close | ±26.58% | -9.21% (in line) |
| 2023/Q4 | 2024-03-28 | After close | ±35.36% | -8.27% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Pulse Biosciences discussion 0 comments